Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 99-2152452 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To advance scientific understanding and support the development of therapeutic applications for clinically excessive pain and other negative States in humans and other species.
Principal Officer
Jacob Shwartz-Lucas
Total Revenue
$396K
FY2025
Total Expenses
$63K
FY2025
Net Assets
$334K
Program Ratio
98.4%
expenses on programs
Employees
0
Volunteers
0
Board Members
5
Voting
5
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.